OncoLens vs Sitowie: Revenue, Funding & Team Size Compared
OncoLens generates $2.9M in revenue; Sitowie generates $2.9M. OncoLens and Sitowie are close to the same size by revenue. The table below compares OncoLens and Sitowie on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $2.9M | $2.9M |
| Valuation | $23.5M | $14.7M |
| Funding raised | Not disclosed | $1.9M |
| Team size | 40 | 18 |
| Founded | 2016 | 2018 |
| HQ | Atlanta, United States | Paris, France |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
OncoLens at a glance
OncoLens generates $2.9M in revenue with 40 employees, headquartered in Atlanta, United States.
- Revenue
- $2.9M
- Valuation
- $23.5M
- Team size
- 40
- Founded
- 2016
Developer of a Software as a Service platform intended to replace the labour-intensive process of collecting, presenting and reporting cases for cancer conference. The company's platform merges case-specific clinical decision support…
Sitowie at a glance
Sitowie generates $2.9M in revenue with 18 employees, headquartered in Paris, France.
- Revenue
- $2.9M
- Valuation
- $14.7M
- Funding
- $1.9M
- Team size
- 18
- Founded
- 2018
Sitowie develops SaaS technology and tools to understand the degradation of buildings.
Other OncoLens alternatives
OncoLens competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
OncoLens vs Sitowie: frequently asked questions
Is OncoLens or Sitowie bigger?
OncoLens is the bigger company by revenue, at $2.9M against $2.9M for Sitowie.
How much revenue does OncoLens make?
OncoLens generates $2.9M in annual revenue with a team of 40.
How much revenue does Sitowie make?
Sitowie generates $2.9M in annual revenue with a team of 18.
How much funding has Sitowie raised?
Sitowie has raised $1.9M in total funding since it was founded in 2018.